Search

Displaying results 6061 - 6070 of 10000 in total
  1. Drug

    Talactoferrin alfa

    go.drugbank.com/drugs/DB05426
    Investigational

    Lactoferrin, a protein found in breast milk is developed by Agennix.

  2. Drug

    Feprazone

    go.drugbank.com/drugs/DB13364
    Experimental

    Categories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDS
  3. Drug

    IDM-2

    go.drugbank.com/drugs/DB05293
    Experimental

    IDM produces MAK cells from the patient's own white blood cells by activating these cells ex vivo to allow them to recognize and destroy tumor cells.

  4. Drug

    Teneligliptin

    go.drugbank.com/drugs/DB11950
    Investigational

    Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus.

    Categories: Drugs Used in Diabetes
  5. Drug

    Lutetium Lu177 Edotreotide

    go.drugbank.com/drugs/DB17278
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Pipendoxifene

    go.drugbank.com/drugs/DB05414
    Investigational

    ER modulator, ERA-923(Pipendoxifene) is a estrogen receptor modulator being evaluated for the treatment of breast cancer. … Pipendoxifene is a new 2-phenyl indole selective estrogen receptor modulators (SERM )that exhibits an excellent preclinical pharmacological profile and was selected for further development as a treatment

  7. Drug

    Alicaforsen

    go.drugbank.com/drugs/DB06224
    Investigational

  8. Drug

    Oxantel

    go.drugbank.com/drugs/DB13670
    Investigational

    Oxantel is an anthelmintic drug that targets parasitic acetylcholine receptors.[A275093, A275098]

  9. Drug

    Bradanicline

    go.drugbank.com/drugs/DB06090
    Investigational

    Bradanicline, a novel small molecule that modulates the activity of the neuronal nicotinic receptor (NNR) subtype known as alpha7(α7). Bradanicline belongs to a new class of drugs for the treatment of central nervous system diseases and ...

  10. Drug

    Tofisopam

    go.drugbank.com/drugs/DB08811
    Investigational

    The D-enantiomer ([dextofisopam]) is currently in phase II trials in the U.S. for the treatment of irritable bowel syndrome. … Although Tofisopam is not approved for sale in North America, it is approved for use in various countries worldwide, including parts of Europe.